|
Subgroup analysis for hepatitis B co-infection among prisoners living with HIV
| |
|
WHO regions
|
Region of the Americas
|
3
|
5
|
3–7
|
0
|
1.75 (-3.37 to 6.87)
|
0.48
|
|
European of region
|
11
|
18
|
10–26
|
97.22
|
|
Western Pacific
|
2
|
27
|
23–31
|
0
|
|
South-East of Asia
|
1
|
3
|
1–11
|
0
|
|
Eastern Mediterranean region
|
5
|
3
|
0–5
|
24.16
|
|
African region
|
1
|
15
|
8–27
|
0
|
|
Study design
|
Cross-sectional
|
20
|
11
|
6–15
|
96.30
|
-6.28 (-33.45 to 20.88)
|
0.63
|
|
Cohort
|
3
|
5
|
4–7
|
0
|
|
Quality of study
|
High
|
10
|
8
|
3–13
|
94.02
|
-6.36 (-17.83 to 5.09)
|
0.26
|
|
Moderate
|
8
|
17
|
5–28
|
96.24
|
|
Low
|
5
|
18
|
9–28
|
97.74
|
|
Sample size
|
< 50
|
6
|
21
|
0–43
|
96.64
|
-10.05 (-30.98 to 10.87)
|
0.32
|
|
> 50
|
17
|
10
|
7–13
|
95.34
|
|
Year
|
< 2005
|
5
|
38
|
16–59
|
99.04
|
-8.61 (-15.96 to -1.25)
|
0.02
|
|
2006–2010
|
8
|
6
|
4–8
|
34.60
|
|
2011–2015
|
4
|
3
|
0–6
|
30.21
|
|
> 2015
|
6
|
5
|
3–8
|
54.80
|
|
Subgroup analysis for Hepatitis C co-infection among prisoners living with HIV
| |
|
WHO regions
|
Region of the Americas
|
17
|
45
|
38–53
|
98.25
|
-6.81 (-11.28 to -2.34)
|
0.004
|
|
European of region
|
21
|
64
|
50–79
|
99.22
|
|
Western Pacific region
|
3
|
75
|
40–100
|
0
|
|
South-East of Asia region
|
2
|
83
|
74–91
|
0
|
|
Eastern Mediterranean region
|
7
|
83
|
73–93
|
92.69
|
|
Study design
|
Cross-sectional
|
46
|
62
|
52–72
|
99.40
|
-6.38 (-37.32 to 24.55)
|
0.68
|
|
Cohort
|
4
|
56
|
21–91
|
99.44
|
|
Quality of study
|
High
|
16
|
66
|
55–77
|
97.51
|
-2.78 (-14.58 to 9.01)
|
0.63
|
|
Moderate
|
24
|
54
|
39–69
|
99.60
|
|
Low
|
10
|
75
|
53–96
|
99.48
|
|
Sample size
|
< 50
|
17
|
62
|
46–77
|
96.43
|
0.07 (-17.55 to 17.71)
|
0.99
|
|
> 50
|
33
|
662
|
51–73
|
99.62
|
|
Year
|
< 2005
|
11
|
61
|
36–86
|
99.45
|
-6.75 (-14.10 to 0.59)
|
0.20
|
|
2006–2010
|
13
|
71
|
53–90
|
99.61
|
|
2011–2015
|
13
|
71
|
56–86
|
97.15
|
|
> 2015
|
13
|
42
|
25–59
|
99.46
|
